REVIEW
Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update
Department of Laboratory Medicine and Pathobiology, University of Toronto, University Health Network, Toronto, Ontario, Canada
Correspondence to:
Correspondence to:
Dr A M Herzenberg
Princess Margaret Hospital, UHN, Room 4-302, 610 University Avenue, Toronto, Canada, M5G 2M9; andrew.herzenberg{at}uhn.on.ca
Diabetic nephropathy is a common cause of end-stage renal disease worldwide. It is characterised by diffuse or nodular glomerulosclerosis, afferent and efferent hyaline arteriolosclerosis, and tubulointerstitial fibrosis and atrophy. Diffuse and nodular diabetic glomerulosclerosis share similar histological features with other clinical conditions. Immunofluorescence and electron microscopy studies, and clinicopathological correlation are essential to differentiate diabetic nephropathy from other conditions that result in diffuse and nodular glomerulosclerosis.
Abbreviations: GBM, glomerular basement membrane; ING, idiopathic nodular glomerulosclerosis; MIDD, monoclonal immunoglobulin deposition disease; PAS, periodic acid Schiff; TBM, tubular basement membrane
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Qian, Y., Feldman, E., Pennathur, S., Kretzler, M., Brosius, F. C. III
(2008). From Fibrosis to Sclerosis: Mechanisms of Glomerulosclerosis in Diabetic Nephropathy. Diabetes
57: 1439-1445
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
